Stay updated with breaking news from Jack Anders. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Revolution Medicines, Inc. (NASDAQ:RVMD) Q4 2023 Earnings Call Transcript February 26, 2024 Revolution Medicines, Inc. misses on earnings expectations. Reported EPS is $-1.14 EPS, expectations were $-0.86. Revolution Medicines, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day […]
Revolution Medicines (NASDAQ:RVMD – Get Free Report) posted its quarterly earnings data on Monday. The company reported ($1.14) EPS for the quarter, missing analysts’ consensus estimates of ($0.85) by ($0.29), Briefing.com reports. Revolution Medicines had a negative net margin of 1,003.36% and a negative return on equity of 38.92%. The firm had revenue of $0.74 […]
Shares of Revolution Medicines, Inc. (NASDAQ:RVMD – Get Free Report) have received a consensus rating of “Moderate Buy” from the nine brokerages that are currently covering the company, Marketbeat reports. One research analyst has rated the stock with a hold rating and eight have issued a buy rating on the company. The average twelve-month price […]
Revolution Medicines, Inc. (NASDAQ:RVMD – Get Free Report) CFO Jack Anders sold 1,775 shares of the business’s stock in a transaction dated Monday, December 18th. The stock was sold at an average price of $25.90, for a total value of $45,972.50. Following the sale, the chief financial officer now owns 76,416 shares in the company, […]
BVF Inc. IL increased its stake in Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) by 26.2% during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 6,255,588 shares of the company’s stock after buying an additional 1,300,000 shares during the period. Revolution Medicines accounts for about […]